A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Fresenius Kabi
- 15 Feb 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India
- 03 Jul 2009 New source identified and integrated (Clinical Trials Registry - India record no. CTRI2009-091-000219).
- 03 Jul 2009 Additional trial identifier UTRN115924240-290420096391230 and CTRI2009-091-000219 identified as reported by Clinical Trials Registry - India.